Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.
Saved in:
| Title: | Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma. |
|---|---|
| Authors: | Stiff, Patrick J.1 (AUTHOR), Czerlanis, Cheryl M.1,2 (AUTHOR), Potkul, Ronald K.2,3 (AUTHOR), Liotta, Margaret2,4 (AUTHOR), Yu, Zheng3,5 (AUTHOR), Pease, Lori3,6 (AUTHOR), Banerjee, Swarnali4 (AUTHOR), Mehrotra, Swati5 (AUTHOR), Winder, Abigail2 (AUTHOR), Guevara, Jennifer6 (AUTHOR), Palmer, Diane6 (AUTHOR), Drakes, Maureen L.1 (AUTHOR) mdrakes@luc.edu |
| Source: | Cancers. Apr2026, Vol. 18 Issue 8, p1285. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
